1. |
Standish RA, Cholongitas E, Dhillon A, et al. An appraisal of the histopathological assessment of liver fibrosis [J]. Gut, 2006; 55(4): 569-578.
|
2. |
Grant A, Neuberger J. Guidelines on the use of liver biopsy in clinical practice. British Society of Gastroenterology [J]. Gut, 1999; 45(Suppl 4): Ⅳ1-Ⅳ11.
|
3. |
Pinzani M. Non-invasive evaluation of hepatic fibrosis: don’t count your chickens before they’re hatched [J]. Gut, 2006; 55(3): 310-312.
|
4. |
Sebastiani G, Vario A, Guido M, et al. Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B [J]. World J Gastroenterol, 2007; 13(4): 525-531.
|
5. |
Guha IN, Parkes J, Roderick PR, et al. Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease [J]. Gut, 2006; 55(11): 1650-1660.
|
6. |
Poynard T, Morra R, Halfon P, et al. Meta-analyses of FibroTest diagnostic value in chronic liver disease [J]. BMC Gastroenterol, 2007; 7: 40.
|
7. |
Rossi E, Adams LA, Bulsara M, et al. Assessing liver fibrosis with serum marker models [J]. Clin Biochem Rev, 2007; 28(1): 3-10.
|
8. |
Halfon P, Bourlière M, Pénaranda G, et al. Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus [J]. Comp Hepatol, 2005; 4: 6.
|
9. |
Rosenberg WM, Voelker M, Thiel R, et al. Serum markers detect the presence of liver fibrosis: a cohort study [J]. Gastroenterology, 2004; 127(6): 1704-1713.
|
10. |
Shen L, Li JQ, Zeng MD, et al. C Correlation between ultrasonographic and pathologic diagnosis of liver fibrosis due to chronic virus hepatitis [J]. World J Gastroenterol, 2006; 12(8): 1292-1295.
|
11. |
Blomley MJ, Lim AK, Harvey CJ, et al. Liver microbubble transit time compared with histology and Child-Pugh score in diffuse liver disease: a cross sectional study [J]. Gut, 2003; 52(8): 1188-1193.
|
12. |
Lim AK, Taylor-Robinson SD, Patel N, et al. Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C [J]. Gut, 2005; 54(1): 128-133.
|
13. |
罗小华, 宋彬, 陈卫霞. 慢性乙型肝炎CT表现与病情程度的关系 [J]. 中华肝脏病杂志, 2005; 13(3): 190-193.
|
14. |
童隆正, 王新光, 贺文. 关于CT图像肝纤维化评定标准的研究 [J]. 医疗设备信息, 2001; 12(16): 9-11.
|
15. |
宋彬. CT灌注成像的原理、技术及在腹部影像诊断中的应用 [J]. 中国普外基础与临床杂志, 2004; 11(2): 171-174.
|
16. |
吴苾, 宋彬. 影像学新技术在消化系统的临床应用 [J]. 中国普外基础与临床杂志, 2007; 14(2): 222-229.
|
17. |
江利, 杨建勇, 杨旭峰, 等. 肝脏CT灌注成像技术及其在肝硬化中的初步应用 [J]. 临床放射学杂志, 2004; 23(3): 214-217.
|
18. |
Guan S, Zhao WD, Zhou KR, et al. CT perfusion at early stage of hepatic diffuse disease [J]. World J Gastroenterol, 2005; 11(22): 3465-3467.
|
19. |
上海市肝纤维化课题协作组. 肝纤维化的CT、 MR 诊断初步探讨 [J]. 上海医学, 2002; 25(4): 210-213.
|
20. |
Ito K, Mitchell DG, Hann HW, et al. Viral-induced cirrhosis: grading of severity using MR imaging [J]. AJR Am J Roentgenol, 1999; 173(3): 591-596.
|
21. |
陈克敏, 钟亮, 柴维敏, 等. 肝纤维化门脉血流的磁共振相位对比法测定 [J]. 临床放射学杂志, 2001; 20(1): 53-55.
|
22. |
Aguirre DA, Behling CA, Alpert E, et al. Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging [J]. Radiology, 2006; 239(2): 425-437.
|
23. |
王秋实, 郭启勇, 梁长虹, 等. MR弥散加权成像评价肝纤维化的初步实验研究 [J].解剖学研究, 2007; 29(3): 212-216.
|
24. |
管生, 赵卫东, 周康荣, 等. 磁共振功能弥散成像对肝脏早期弥漫性病变诊断价值的实验研究 [J]. 中华肝脏病杂志, 2005; 13(7): 524-527.
|
25. |
沈文, 尹建忠, 张龙江, 等. 肝纤维化和肝硬化的MR扩散成像及与病理对照、CT灌注参数的相关性研究 [J]. 临床放射学杂志, 2007; 26(10): 1000-1004.
|
26. |
Aubé C, Racineux PX, Lebigot J, et al. Diagnosis and quantification of hepatic fibrosis with diffusion weighted MR imaging: preliminary results [J]. J Radiol, 2004; 85(3): 301-306.
|
27. |
吴苾, 宋彬, 杨洋. 肝脏31P-MR波谱成像的临床应用 [J]. 中国普外基础与临床杂志, 2005; 12(6): 624-627.
|
28. |
崔恩铭, 谭理连, 李志铭, 等. 健康成人肝脏31P-MR 波谱研究 [J]. 放射学实践, 2007; 22(11): 1189-1192.
|
29. |
崔恩铭, 谭理连, 李志铭, 等. 慢性乙型肝炎患者31P MRS 与血清肝功能相关性研究 [J]. 中国临床医学影像杂志, 2007; 18(11): 789-792.
|
30. |
张艺军, 郭玉峰, 周怀琪, 等. 1HMRS在定性诊断乙肝后早期肝硬化中的初步研究 [J]. 现代生物医学进展, 2007; 7(7): 1061-1064.
|
31. |
Xu L, Gao PY. “Palpation by imaging”: magnetic resonance elastography [J]. Chin Med Sci J, 2006; 21(4): 281-286.
|
32. |
Cobbold JF, Morin S, Taylor-Robinson SD. Transient elastography for the assessment of chronic liver disease: ready for the clinic [J]. World J Gastroenterol, 2007; 13(36): 4791-4797.
|
33. |
Foucher J, Chanteloup E, Vergniol J, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study [J]. Gut, 2006; 55(3): 403-408.
|
34. |
Moreno-Otero R, Trapero-Marugan M, Mendoza J. Liver fibrosis assessment by transient elastography in hepatitis C patients with normal alanine aminotransferase [J]. Gut, 2006; 55(7): 1055-1056.
|
35. |
Takeda T, Yasuda T, Nakayama Y, et al. Usefulness of noninvasive transient elastography for assessment of liver fibrosis stage in chronic hepatitis C [J]. World J Gastroenterol, 2006; 12(48): 7768-7773.
|
36. |
Fraquelli M, Rigamonti C, Casazza G, et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease [J]. Gut, 2007; 56(7): 968-973.
|